Seeking Alpha

GERN
Geron Corporation - NASDAQ

4/16/2014, 9:37 PM ET
Quote & Analysis Breaking News StockTalk
gern chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
PRO Articles
There is research on this stock available only to PRO subscribers.
Other Articles
GERN vs. ETF Alternatives
Company Description

Geron Corporation is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic products for oncology such as telomerase inhibitor, imetelstat and in hematologic myeloid malignancies, among others.

Sector: Healthcare
Industry: Biotechnology
Country: United States